211 related articles for article (PubMed ID: 29656365)
1. Characterization of AAV vector particle stability at the single-capsid level.
Bernaud J; Rossi A; Fis A; Gardette L; Aillot L; Büning H; Castelnovo M; Salvetti A; Faivre-Moskalenko C
J Biol Phys; 2018 Jun; 44(2):181-194. PubMed ID: 29656365
[TBL] [Abstract][Full Text] [Related]
2. Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release.
Horowitz ED; Rahman KS; Bower BD; Dismuke DJ; Falvo MR; Griffith JD; Harvey SC; Asokan A
J Virol; 2013 Mar; 87(6):2994-3002. PubMed ID: 23269804
[TBL] [Abstract][Full Text] [Related]
3. Resolving Adeno-Associated Viral Particle Diversity With Charge Detection Mass Spectrometry.
Pierson EE; Keifer DZ; Asokan A; Jarrold MF
Anal Chem; 2016 Jul; 88(13):6718-25. PubMed ID: 27310298
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of adeno-associated virus capsid stability and dynamics.
Rayaprolu V; Kruse S; Kant R; Venkatakrishnan B; Movahed N; Brooke D; Lins B; Bennett A; Potter T; McKenna R; Agbandje-McKenna M; Bothner B
J Virol; 2013 Dec; 87(24):13150-60. PubMed ID: 24067976
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
[TBL] [Abstract][Full Text] [Related]
6. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M
Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.
Yan Z; Zak R; Luxton GW; Ritchie TC; Bantel-Schaal U; Engelhardt JF
J Virol; 2002 Mar; 76(5):2043-53. PubMed ID: 11836382
[TBL] [Abstract][Full Text] [Related]
8. Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9.
Kohlbrenner E; Weber T
Methods Mol Biol; 2017; 1521():91-107. PubMed ID: 27910043
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.
Dane AP; Wowro SJ; Cunningham SC; Alexander IE
Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507
[TBL] [Abstract][Full Text] [Related]
10. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.
Grimm D; Kern A; Pawlita M; Ferrari F; Samulski R; Kleinschmidt J
Gene Ther; 1999 Jul; 6(7):1322-30. PubMed ID: 10455443
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
12. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
13. Empty and Full AAV Capsid Charge and Hydrophobicity Differences Measured with Single-Particle AFM.
Heldt CL; Areo O; Joshi PU; Mi X; Ivanova Y; Berrill A
Langmuir; 2023 Apr; 39(16):5641-5648. PubMed ID: 37040364
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
Mietzsch M; Barnes C; Hull JA; Chipman P; Xie J; Bhattacharya N; Sousa D; McKenna R; Gao G; Agbandje-McKenna M
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826994
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
Shen X; Storm T; Kay MA
Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
17. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
Grimm D; Büning H
Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
[TBL] [Abstract][Full Text] [Related]
18. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.
Thomas CE; Storm TA; Huang Z; Kay MA
J Virol; 2004 Mar; 78(6):3110-22. PubMed ID: 14990730
[TBL] [Abstract][Full Text] [Related]
19. Rational downstream development for adeno-associated virus full/empty capsid separation - A streamlined methodology based on high-throughput screening and mechanistic modeling.
Keller WR; Picciano A; Wilson K; Xu J; Khasa H; Wendeler M
J Chromatogr A; 2024 Feb; 1716():464632. PubMed ID: 38219623
[TBL] [Abstract][Full Text] [Related]
20. Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals.
Asokan A; Johnson JS; Li C; Samulski RJ
Gene Ther; 2008 Dec; 15(24):1618-22. PubMed ID: 18668144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
